(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 5.79% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.06%.
Bausch & Lomb's revenue in 2026 is $5,208,000,000.On average, 16 Wall Street analysts forecast BLCO's revenue for 2026 to be $1,975,924,496,036, with the lowest BLCO revenue forecast at $1,886,790,406,536, and the highest BLCO revenue forecast at $2,044,379,476,772. On average, 15 Wall Street analysts forecast BLCO's revenue for 2027 to be $2,086,450,767,016, with the lowest BLCO revenue forecast at $1,979,846,395,974, and the highest BLCO revenue forecast at $2,171,306,420,220.
In 2028, BLCO is forecast to generate $2,198,403,183,428 in revenue, with the lowest revenue forecast at $2,064,345,512,820 and the highest revenue forecast at $2,300,016,045,458.